Startseite
Impressum
Datenschutz
 
 
  SPOT ON
 

Bevacizumab (AVASTIN) against cancer … with money-back guarantee for hospitals

 
  NEW ON THE MARKET
 

Xylometazoline + ipratropium bromide (OTRIVEN DUO) against rhinitis

Attention-deficit hyperactivity disorder: methylphenidate for adults?

 
  a-t READER'S QUESTIONS AND COMMENTS
 

Reducing lipoprotein(a) with nicotinic acid?

 
  THERAPY FROM A CRITICAL VIEWPOINT
 

Early benefit assessment of ticagrelor (BRILIQUE) by IQWiG

"Individual health services" (IGeL) reviewed … screening for glaucoma, ovarian and endometrial cancer without proven benefit

 
  IN BRIEF
 

Cave: hyperkalemia with spironolactone plus trimethoprim

Marketing via "market research"

 
  CURRENT ADR NETWORK REPORT
 

Breast cancer with glatiramer acetate (COPAXONE)

 
  SIDE EFFECTS

Dronedarone (MULTAQ): restriction of indication and warnings instead of market withdrawal

 
  e a-t IN THE INTERNET
 

Cardiovascular risks of varenicline (CHAMPIX)

 
© arznei-telegramm 10/2011